A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer.
Eur Urol Oncol
; 2023 Nov 07.
Article
in En
| MEDLINE
| ID: mdl-37945488
Full text:
1
Database:
MEDLINE
Language:
En
Year:
2023
Type:
Article